Skip to main content
ADIM logo

ADIM — Investor Relations & Filings

Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,804 across all filing types
Latest filing 2018-11-07 Director's Dealing
Country TW Taiwan
Listing TW 4142

About ADIM

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
107年10月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tabular data about shareholdings of insiders, including directors, general managers, and their related parties. It lists the number of shares held, changes in holdings, and classifications of shares for various insiders. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but a detailed disclosure of insider shareholdings and transactions. Therefore, the appropriate classification is Director's Dealing (DIRS).
2018-11-07 Chinese
說明媒體報導
Regulatory Filings Classification · 95% confidence The document is a short announcement (1157 characters) from a company (國光生物科技股份有限公司) explaining a media report about a vaccine issue. It provides details about the incident, the company's response, and states there is no significant financial impact. There are no financial statements, no detailed financial data, no regulatory certifications, or report attachments. The document is a regulatory announcement clarifying a media report and company actions, fitting best under Regulatory Filings (RNS) as it does not match other specific categories like Annual Report, Earnings Release, or Legal Proceedings Report.
2018-10-30 Chinese
公告本公司法人董事改派代表人
Board/Management Information Classification · 100% confidence The document is a short announcement about a change in the company's board representation, specifically the replacement of a legal representative director. It includes details such as the old and new representative names, dates of change, and related information. There is no financial data, no mention of financial results, reports, or regulatory filings beyond this management change. The document length is only 601 characters, indicating it is a brief announcement rather than a full report. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2018-10-29 Chinese
公告本公司107年9月份自結財務報表中，高流動性資產及短 期借款等相關資訊
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (國光生) providing specific financial data for September 2018 (107/09 in ROC calendar) including cash, short-term borrowings, and other liquidity-related items. It references compliance with a Taiwan Stock Exchange directive and provides a brief explanation of the company's liquidity status. The document length is only 857 characters, which is very short and contains no comprehensive financial statements or detailed analysis. It is essentially a regulatory disclosure of financial information rather than a full financial report. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Interim Report (IR) or Annual Report (10-K).
2018-10-23 Chinese
107年9月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 國光生, providing information about loan balances and endorsement guarantees for the current and previous months. The content is very short (614 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. There is no indication that this is a full financial report, audit, or management discussion. It appears to be a regulatory disclosure or compliance update related to financial guarantees. Given the short length and nature of the content, it does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2018-10-09 Chinese
107年9月營業收入
Regulatory Filings Classification · 90% confidence The document is a revenue summary report for a specific month and year (民國107年09月, which corresponds to 2018 September) provided by a listed company (國光生). It contains monthly and cumulative revenue figures with percentage changes and explanations for revenue fluctuations. The document is short (802 characters) and does not contain comprehensive financial statements or detailed analysis. It appears to be a periodic revenue update rather than a full interim or annual report. There is no indication that this is an earnings release (which typically highlights key financial results in a press release format), nor is it a full interim report with detailed financial statements. Given the nature of the data and the length, this fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth of an Interim Report (IR) or Annual Report (10-K).
2018-10-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.